Control of Thrombin Mediated Cleavage of Protein S

Summary

Thrombin has been shown to cleave the vitamin K dependent cofactor protein S with subsequent loss of its cofactor activity. This study examines the control mechanisms for thrombin cleavage of protein S.

The anticoagulant activity of activated protein C (APC) is enhanced fourteen fold by the addition of protein S. Thrombin cleaved protein S is seven fold less efficient than the native protein, and this loss of activity is due to reduced affinity of cleaved protein S for APC or the lipid surface compared to the intact protein.

In the absence of Ca⁺⁺, protein S is very sensitive to minimal concentrations of thrombin. As little as 1.5 nM thrombin results in complete cleavage of 20 nM protein S in 10 min and loss of cofactor activity. Ca⁺⁺, in concentrations greater than 0.5 mM, will inhibit this cleavage and in the presence of physiological Ca++ concentrations, no cleavage of protein S could be demonstrated in spite of high concentrations of thrombin (up to 1 μM) and prolonged incubations (up to two hours). The endothelial surface protein thrombomodulin is very efficient in inhibiting the cleavage of protein S by thrombin suggesting that any thrombin formed on the endothelial cell surface is unlikely to cleave protein S, thus allowing the intact protein to act as a cofactor to APC.

We conclude that the inhibitory effects of Ca⁺⁺ and thrombomodulin on thrombin mediated cleavage of protein S imply that this event, by itself, is unlikely to represent a physiological control of the activity of protein S.

Keywords

Protein S - Thrombomodulin - Thrombin - Protein C

• References

• 1 Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-5831
• 2 Salem HH, Broze GJ, Miletich JP, Majerus PW. The light chain of factor Va contains the activity of factor V_a that accelerates protein C activation by thrombin. J Biol Chem 1983; 258: 8531-8533
• 3 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proceedings of the National Academy of Sciences, USA 1982; 78: 859-864
• 4 Esmon NL, Owen WG, Esmon CT. Isolation of a membrane bound cofactor for thrombin catalyzed activation of protein C. J Biol Chem 1982; 257: 859-864
• 5 Salem HH, Maruyama I, Ishii H, Majerus PW. Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 1984; 259: 12246-12251
• 6 Salem HH, Esmon NL, Esmon CT, Majerus PW. Effects of thrombomodulin and coagulation factor Va-light chain on protein C activation in vitro. J Clin Invest 1984; 73: 968-972
• 7 Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333-342
• 8 Marlar RR, Kleiss A, Griffin J. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072
• 9 Walker FJ. Regulation of activated protein C by a new protein. J Biol Chem 1980; 255: 5521-5524
• 10 Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-11131
• 11 Harris KW, Esmon CT. Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 1985; 260: 2007-2010
• 12 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
• 13 Comp P, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. New England J Med 1984; 311: 1525-1528
• 14 Dahlback B. Purification of human vitamin K dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-846
• 15 Walker FJ. Regulation of vitamin K dependent protein S. J Biol Chem 1984; 259: 10335-10339
• 16 Suzuki K, Nishioka J, Hashimoto S. Regulation of activated protein C by thrombin modified protein S. J Biochem 1983; 94: 699-708
• 17 Miletich JP, Broze GJ, Majerus PW. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX and X. Anal Biochem 1980; 105: 304-310
• 18 Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on human platelets. J Biol Chem 1978; 253: 6908-6916
• 19 Owen WG. Evidence for the formation of an ester between thrombin and heparin cofactor. Biochim Biophys Acta 1975; 405: 380-387
• 20 Salem HH, Maruyama I, Ishii I, Majerus PW. Isolation and characterization of thrombomudulin from human placenta. J Biol Chem 1984; 259: 12246-12251
• 21 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
• 22 Discipio RG, Davie EW. Characterisation of protein S, a y-carboxyglutamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904
• 23 Maruyama I, Salem HH, Majerus PW. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation. J Clin Invest 1984; 74: 224-230
• 24 Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin catalysed fibrin formation and factor V activation. J Biol Chem 1982; 257: 7944-7947